Dr. Mark Thornton, who spent six years as a medical officer at the Food and Drug Administration and is the president of the Sarcoma Foundation of America, calls for speedier clinical trials in this opinion piece in the Wall Street Journal.
The federal stimulus plan will give the National Institutes of Health $10 billion, with a significant portion going to the National Cancer Institute. But, Dr. Thornton says, we’ve been here before. A surge in spending on cancer research from 1999 to 2003 (complete with a march on Washington) accomplished scant success, he writes. And, despite President Obama’s lofty goals, “it appears that the NCI is not mapping out a specific plan or strategy on how to most effectively use its new money.” Dr. Thornton now works in the biotechnology industry.